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Abstract
Background: The p53 tumor suppressor protein is involved in a complicated regulatory network, mediating
expression of ~1000 human genes. Recent studies have shown that many p53 in vivo binding sites (BSs) reside in
transposable repeats. The relationship between these BSs and functional p53 response elements (REs) remains
unknown, however. We sought to understand whether the p53 REs also reside in transposable elements and
particularly in the most-abundant Alu repeats.
Results: We have analyzed ~160 functional p53 REs identified so far and found that 24 of them occur in repeats.
More than half of these repeat-associated REs reside in Alu elements. In addition, using a position weight matrix
approach, we found ~400,000 potential p53 BSs in Alu elements genome-wide. Importantly, these putative BSs are
located in the same regions of Alu repeats as the functional p53 REs - namely, in the vicinity of Boxes A/A’ and B
of the internal RNA polymerase III promoter. Earlier nucleosome-mapping experiments showed that the Boxes A/A’
and B have a different chromatin environment, which is critical for the binding of p53 to DNA. Here, we compare
the Alu-residing p53 sites with the corresponding Alu consensus sequences and conclude that the p53 sites likely
evolved through two different mechanisms - the sites overlapping with the Boxes A/A’ were generated by CG ®
TG mutations; the other sites apparently pre-existed in the progenitors of several Alu subfamilies, such as AluJo
and AluSq. The binding affinity of p53 to the Alu-residing sites generally correlates with the age of Alu subfamilies,
so that the strongest sites are embedded in the ‘relatively young’ Alu repeats.
Conclusions: The primate-specific Alu repeats play an important role in shaping the p53 regulatory network in the
context of chromatin. One of the selective factors responsible for the frequent occurrence of Alu repeats in introns
may be related to the p53-mediated regulation of Alu transcription, which, in turn, influences expression of the
host genes.
Reviewers: This paper was reviewed by Igor B. Rogozin (nominated by Pavel A. Pevzner), Sandor Pongor, and I.
King Jordan.
Background
P53 is one of the best-known tumor suppressor pro-
teins, and is involved in an amazingly complicated regu-
latory network [1-3]. In response to various kinds of
cellular stress, p53 induces activation and repression of
more than a thousand human genes [4]. The p53 pro-
tein possesses the classical features of a eukaryotic tran-
scription factor, including a sequence-specific DNA
binding domain (DBD), as well as transactivation and
tetramerization domains. Upon activation, the p53 tetra-
mer binds to DNA sequence-specifically, but this
specificity is extremely degenerate. A typical p53 binding
site (BS) comprises two decamers RRRCWWGYYY
separated by a variable spacer, S [5]; see Figure 1. (Here,
Ri sp u r i n e ;Yi sp y r i m i d i n e ;Wi sAo rT . )T h es t r o n -
gest p53 sites, such as p21, have spacer S = 0, but
spacers as long as S = 18 bp can also be functional [6].
As a consequence of this degeneracy, the human gen-
ome contains enormous numbers of potential p53 BSs.
The functional significance of the vast majority of these
sites remains unknown, however.
Experimentally, the p53 BSs have been identified by
two approaches: one is a traditional, single-gene
approach, and the other is a genome-wide approach.
The first approach [6] focuses on a specific target gene,
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any medium, provided the original work is properly cited.usually including a transcription assay that uses a repor-
ter-gene construct to determine the specific DNA frag-
ment interacting with p53. (The latter is denoted p53
response element, RE). The second approach [7,8] is
based on cross-linking p53 to genomic DNA, with sub-
sequent extraction of the p53-bound DNA fragments by
chromatin immuno-precipitation (ChIP). Although some
p53 ChIP fragments overlap with previously established
p53 REs such as the p21 5’-site, most of them remain
uncharacterized [7]. One critical distinction between
these two sets of p53 sites lies in their positioning with
respect to the transcription start sites (TSS) of the near-
est genes: while ~70% of p53 REs are located within 2 kb
from TSS, less than 10% of p53 ChIP fragments are
within this range, indicating that physically they reside in
different genomic regions (Additional File 1: Table S1).
Below, we distinguish between the functional p53 REs
proven to be critical for regulation of expression of the
corresponding genes, and the p53 ChIP fragments and
predicted p53 BSs, whose function is mostly unknown.
While the p53-induced activation of transcription has
been studied the most extensively, more than 50% of
p53-modulated genes are repressed by p53, and this
f r a c t i o nm a ya c t u a l l yb ea s high as 80% [9]. However,
the most comprehensive collection published recently
contains ~160 REs for ~130 genes, almost all of which
are activated by p53 [6]. Therefore, our knowledge of
the mechanisms of p53-mediated trans-repression still
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Figure 1 Four p53 core domains bound to bent DNA. It is based on the computational model [45] that was further corroborated by gel
electrophoresis experiments [46]; the overall DNA bend is ~40°. The spacer S between two decamers varies from 0 to 18 bp in the known
functional p53 REs [5,6]. The shown structure corresponds to S = 0. The red arrows show the major-groove bending (M) in the CWWG tetramers;
blue arrow is for the minor-groove bend (m) in the center of the site. The lateral positioning of p53 DBDs on the external side of DNA loop and
the degree of DNA bending imply that in principle, the p53 tetramer can bind to nucleosomal DNA. The dashed lines indicate that the
N-termini N1-N4 are accessible for interactions with trans-activation and trans-repression factors (e.g., histone acetylase, HAT, and histone
deacetylase, HDAC). Large colored arrows indicate the orientations of the four p53 subunits.
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digm, the principal difference between trans-activation
and trans-repression is explained by the alteration of
chromatin structure at target gene promoters through
the p53-induced recruitment of co-activators or co-
repressors, such as histone acetylase, HAT, and histone
deacetylase, HDAC [6,10,11].
To test the hypothesis that the spacer S between two
p53 half-sites is related to the p53-mediated trans-acti-
vation and repression [6,11], we analyzed in silico the
putative p53 BSs in the promoters of genes regulated by
p53 [4]. The stereochemical rationale for this hypothesis
was that the spacer length determines the relative orien-
tation between the two half-sites and between the two
p53 dimers bound to DNA (Figure 1); this, in turn,
determines which co-factors would be recruited to the
p53-DNA complex. We found that the genes which are
up- and down-regulated by p53 do indeed differ in the
spacer length: S = 0 is predominant for the up-regulated
genes, while S = 3 bp is over-represented for the down-
regulated genes [4] (M.V. Sirotin and V.B. Zhurkin,
unpublished observation). These findings are consistent
with the known data for two p53-trans-repressed genes,
MAP4 and survivin, whose p53 REs contain a 3-bp
spacer. Furthermore, deletion of this spacer (that is,
changing the spacer S = 3 to S = 0) converts the survi-
vin p53 site into a trans-activating element [11].
Initially, we found that a significant fraction of the pre-
dicted p53 BSs in the human genome is organized in
multiple tandem repeats and some of these sites are
embedded in the LTR-transposons of THE1-MaLR
family [12]. Later, the list of transposon families contain-
ing the putative p53 sites was extended to include SINE/
Alu, SINE/MIR and LTR/ERV [13]. These results were
substantiated by Haussler and coworkers [14] who ana-
lyzed numerous p53 BSs detected in the p53-ChIP
experiments [7] and showed that ~1500 of these sites are
embedded in ERV LTR regions. Moreover, the distribu-
tions of the length of the spacer, S, derived from human
and mouse genomes proved to be different [15], suggest-
ing that the primate-specific interspersed repeats may
contribute to the observed differences. Therefore, in this
study we further expand this analysis, with the most
attention directed to the primate-specific Alu repeats.
More than one million Alu sequences are scattered
throughout the human genome, representing ~10% of
its length [16]. Recently, it became clear that Alu and
other transposable elements are indispensable for the
evolution of regulatory networks [17-19]. This idea was
first put forward by Britten and Davidson [20]. Later,
numerous Alu elements were found in promoters and
enhancers of genes, suggesting that Alu elements may
function as carriers of cis regulatory elements modulat-
ing gene expression [21-30].I np a r t i c u l a r ,v a r i o u s
transcription factor BSs have been established in Alu
elements, including GATA [31], LyF-1 [31], Sp1 [32,33],
YY1 [33,34] and retinoic acid receptors (RARs) [35].
An important observation was made recently by Vin-
gron and coworkers [36], who found that a substantial
number of p53 sites detected in cross-linking experi-
ments (p53 ChIP fragments) reside in Alu elements.
Comparing the sequences of the p53 sites with their
counterparts in the Alu consensus sequences, the
authors detected multiple CG dinucleotides occurring at
the positions that correspond to the CATG tetramer in
the p53 sites. They therefore proposed that the methyla-
tion and deamination of cytosine that results in the
CG ® TG transition could generate the CATG motifs
attractive to p53 for binding in vivo. (Independently, we
proposed the same mechanism for thousands of pre-
dicted p53 BSs residing in Alu repeats genome-wide
[15].) This mechanism, however, ostensibly differs from
the one proposed earlier for the ERV LTR families by
Haussler and coauthors [14], who argued that the p53
BSs are likely present in progenitor LTRs, not generated
through mutations. Note also that the cited studies did
not address the question whether the Alu elements and
other repeats harbor functional p53 REs directly
involved in regulation of transcription.
To clarify these issues, we analyzed the two ‘extreme’
datasets, functional p53 REs and putative p53 BSs. The
first set contains a relatively small number (~160) of rig-
orously defined p53 REs [6], while the second set of p53
sites, predicted using the position weight matrix
approach PWM-20 (see Methods), includes ~2 million
putative p53 sites in the human genome. We found that
out of the ~160 p53 REs, 24 REs occur in repetitive
DNA, 13 of them residing in Alu repeats. These thirteen
p53 REs are clustered in the three ‘hot-spot’ regions in
Alu repeats, overlapping with the Boxes A/A’ and B of
the internal RNA polymerase III (pol III) promoters.
Importantly, numerous putative p53 BSs are also clus-
tered in the same three regions in Alu repeats. A com-
parison of the sequences of p53 sites and their Alu
counterparts revealed that Alu-residing p53 sites prob-
ably evolved through two different mechanisms: the
s i t e so v e r l a p p i n gw i t hB o x e sA / A ’ were generated by
CG ® TG mutations; the sites overlapping with Box B
apparently pre-existed in the progenitors of the corre-
sponding Alu subfamilies. This indicates that the two
mechanisms for generation of p53 sites proposed earlier
[14,36] may both be operative in the human genome.
Finally, we examined the three ‘hot spots’ in the con-
text of nucleosome positions in Alu repeats [37,38] and
found that the p53 sites near Box B are located in
the nucleosome-free linker region, while the sites over-
lapping with Boxes A/A’ are covered by nucleosomes.
Further analysis of the DNA rotational orientation
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somes in such a way that they are ‘exposed’ on the
nucleosome surface, facilitating p53 binding [39]. Since
the upstream regions of the TSS (several kilobases in
length) are enriched with Alu elements [40], it is concei-
vable that p53 may utilize at least some of the predicted
BSs to modulate transcription of certain groups of the
human genes in response to cellular stresses.
Results
Functional human p53 REs residing in repeats
Analysis of the known p53 sites and their flanking gen-
ome fragments (157 in total, see Methods) revealed 24
functional sites that are located in repeats (Table 1).
These repeats belong to various families, including
SINE/Alu, SINE/MIR, LTR/ERV, consistent with our
earlier predictions [12,13] and the results of analysis of
Table 1 Functional human p53 response elements occurring in repeats
# Gene name
a RE sequence Spacer,
bp
Repeat Assignment (CENSOR/
RepeatMasker)
c
Class/Family
1 GDF15 CATCTTGCCC AGACTTGTCT 0 FLAM_C SINE/Alu
2 BCL2L14 AGCCAAGGCT GGTCTTGAAC 0 AluJr/Jo SINE/Alu
3 CASP10,
RE1
GGGCATGGTG GGACATGCCT 0 AluJo/Jr SINE/Alu
4 CASP10,
RE2
GGGCATGGTG GCACATGCCT 0 AluSp SINE/Alu
5 BID GGGCATGATG GTGCATGCCT 0 AluSg SINE/Alu
6 TSC2, RE1 GGGCATGGTG GCACATGCCT 0 AluSg SINE/Alu
7 EphA2 AGACATGCCT(S)
CAACATGGTG
3 AluSz SINE/Alu
8 HTT (HD) CGCCATGTTG(S)
AGGCTGGTCT
3 AluSq2 SINE/Alu
9 CASP6 AGGCAAGGAG(S)
AGACAAGTCT
4 AluJr SINE/Alu
10 BNIP3L AAGCTAGTCT(S)
GCGCATGCCT
5 AluJo/Jr SINE/Alu
11 AIFM2, RE1 AGACCAGCCT(S)
TAGCGAGACC
8 AluJo SINE/Alu
12 AIFM2,
RE2
b
GGGCATGGCC(S)
GCTCATGCCT
10 AluJo SINE/Alu
13 TSC2, RE2 AGGCTAGTCT(S)
TGACGTGACC
13 AluJb SINE/Alu
14 CCNK
b AAACTAGCTT(S)
AGACATGCTG
2 MIRb SINE/MIR
15 CASP10,
RE3
AAACTTGCTG(S)
AATCTTGGCT
5 MIR SINE/MIR
16 CTSD
b AACCTTGGTT TGCAAGAGGC 0 MER4D LTR/ERV1
17 MMP2 AGACAAGCCT GAACTTGTCT 0 LTR88b LTR/Gypsy
18 SCN3B TGACTTGCTC TGCCTTGCCT 0 THE1B LTR/ERVL-MaLR
19 TP53INP1 GAACTTGGGG GAACATGTTT 0 MER21B LTR/ERVL
20 TRIM22 TGACATGTCT AGGCATGTAG 0 LTR10D LTR/ERV1
21 CRYZ CTGCAAGTCC(S)
AAACCTGTTT
3 THE1B LTR/ERVL-MaLR
22 PLK2 GGTCATGATT(S)
TAACTTGCCT
3 MER34C LTR/ERV1
23 COL18A1 TGACATGTGT GAGCATGTAT 0 (TG)n Simple_repeat
24 SCARA3 GGGCAAGCCC AGACAAGTTG 0 MER81 DNA/hAT-
Blackjac
a In those cases when genes have several REs, they are denoted RE1, RE2, RE3.
b The REs are partially covered (> 5 nt) by repeats.
c CENSOR [61] and RepeatMasker (A.F.A. Smit, R. Hubley, and P. Green, http://www.repeatmasker.org) are used to assign repeats to subfamilies: two assignments
are shown if their predictions are different, whereas only one consensus assignment is shown if their predictions are the same.
Cui et al. Biology Direct 2011, 6:2
http://www.biology-direct.com/content/6/1/2
Page 4 of 20the p53 ChIP fragments obtained in vivo [14,36]. Among
these repeat-associated p53 REs there are several well-
established sites modulating cell cycle arrest genes, such
as CCNK [41], and apoptotic genes, such as AIFM2 [42]
and TP53INP1 [43]. These results confirm the idea that
various repeat families might function as a supply of
p53 BSs in vivo [19].
Note that ~55% of all p53 REs residing in repeats (13
out of 24 REs) are associated with the Alu family
(Table 1). Given that Alu repeats comprise ~25% of all
r e p e a t si nh u m a ng e n o m e ,i ti sr e a s o n a b l et oa s s u m e
that Alu elements in general are characterized by a
higher ‘density’ of p53 sites compared to the other
repeats (see below).
Localization of functional p53 REs in Alu repeats
All p53 REs associated with the Alu subfamilies (Table 1)
are mapped to the three locations (or ‘hot spots’)i nA l u
repeats, around positions 10, 85 and 150 (Figure 2).
These REs can be divided in two groups, A and B,
depending on their proximity to the Boxes A/A’ or B of
the pol III promoters on the left and right monomers of
the Alu element. The hot spots at positions 10 and 150
were identified previously by Zemojtel et al. [36] in the
analysis of in vivo p53 BSs. These authors compared
sequences of the Alu-residing p53 sites to their counter-
parts in repeats and found that the latter were enriched
with the CG dimers, especially in the CNNG core motifs.
Based on this observation it was suggested [36] that
methylation and deamination of CpG could generate
strong motifs CATG for p53 binding in vivo.
Our data are consistent with these results: the Alu
regions aligned to the p53 REs from the group A con-
tain numerous CG dinucleotides (Figure 2 and Addi-
tional File 2: Figure S1). For example, in the case of
TSC2 RE1, the consensus AluSg sequence contains four
CG dimers, all of which are substituted by CA:TG
dimers in the p53 RE. (The large-scale alignment
between the AluSg consensus and the TSC2 RE1
flanked by genomic sequences, leaves practically no
doubt that the Alu repeat was indeed a progenitor of
this functional p53 site - the ‘divergence’ ratio (div) is a
HTT CGCCATGTTGGCCAGGCTGGTCT
AIFM2 GGGCATGGCCAGGCACGGTGGCTCATGCCT 21
HTT CGCCATGTTGGCCAGGCTGGTCT
|||||||||||||||||||||||
AluSq2 CGCCATGTTGGCCAGGCTGGTCT
1 280 120 135
AIFM2 GGGCATGGCCAGGCACGGTGGCTCATGCCT
(RE2) |||| ||| |||||||||| ||||
AluJo GGCCGGGCGCGGTGGCTCACGCCT
GGGCATGGTGGCACATGCCT TSC2 RE1
|||| ||||||| |  ||||
GGGCGTGGTGGCGCGCGCCT AluSg
1 280 120 135
150 85
BID AIFM2 RE1
10
AIFM2 RE2
B A A’
BID
BNIP3L
CASP10, RE1
CASP10, RE2
TSC2 RE1
AIFM2, RE1
BCL2L14
CASP6
EphA2
GDF15
AIFM2, RE2
TSC2 RE1 GDF15
HTT
TSC2, RE2
S=0 in 4/5 (80%) S=0 in 2/7 (29%)
Spacer  0 Spacer = 0
Figure 2 Mapping functional p53 sites on Alu repeats. The left and right Alu monomers are represented by rectangles; the inter-monomer
region and the 3’-tail are shown by lines. Thirteen p53 REs residing in Alu repeats (Table 1) are localized around positions 10, 85 and 150
overlapping with Boxes A, B and A’. The p53 REs are listed according to their localization in Alu, and the ones with spacer S = 0 are underlined.
Alignments of selected p53 REs with the corresponding Alu subfamily consensus sequences are shown. The p53 core motifs CNNG and the
corresponding regions in Alu elements are highlighted in boldface. The CG dinucleotides are shown in red. Note that the two p53 REs
associated with the AIFM2 gene are localized in the same repeat AluJo (Additional File 3: Figure S2) and separated by one superhelical turn of
DNA in nucleosome. In such a case, two p53 tetramers can bind cooperatively on the same side of the nucleosomal surface [12], thereby
increasing their affinity to DNA. Simultaneous mutations in Boxes A and B (producing two p53 half-sites in the same Alu repeat, separated by
S = 75 bp) are likely to happen relatively often. This can explain an unusually frequent occurrence of the spacer S = 75 bp observed earlier [12].
Cui et al. Biology Direct 2011, 6:2
http://www.biology-direct.com/content/6/1/2
Page 5 of 20mere 10.5% for the 290 bp-long DNA fragments (Addi-
tional File 3: Figure S2). For the thirteen p53 REs
aligned to Alu repeats, this ratio varies from 8.7 to
18.1%, in most cases being less than 15%.)
Note that the CG dimers have been frequently substi-
tuted not only in the CNNG tetramers, as was empha-
sized by Zemojtel et al. [36], but rather in the whole
~20 bp-long Alu regions corresponding to the p53 sites
(Figure 2 and Additional File 2: Figure S1). In general,
however, our analysis of the p53 REs confirms the obser-
vations made earlier [36] and provides an additional evi-
dence that the CG ® TG transition was a driving force
in creating functional p53 sites embedded in Alu repeats
at hot spots 10 and 150 (Boxes A/A’ in Figure 2).
The p53 REs mapped to Alu repeats around position 85
(Box B in Figure 2) comprise a novel group of p53 sites
(denoted as the group B), which differ from the sites
described above in several aspects. First, the average den-
sity of CG dinucleotides and the number of apparent
CG ® T Gt r a n s i t i o n si sm u c hl o w e ri nt h eg r o u pB
(Additional File 2: Figure S1). In particular, comparison
of the CNNG core motifs in the p53 sites and in their
Alu counterparts shows that there is only one CG ® TG
transition in the seven REs from group B (BCL2L14 in
Additional File 2: Figure S1). By contrast, for the six REs
in group A, there are 16 such transitions (the corre-
sponding CG dimers are highlighted in magenta in Addi-
tional File 2: Figure S1).
Second, the total number of mutations distinguishing
the p53 REs from their Alu precursors is also smaller
for the group B. The mutation rate for the group B is
nearly twice as small as that for the group A - 0.14 and
0.23 substitutions per base pair, respectively (the num-
bers of substitutions for each p53 site are given in Addi-
tional File 2: Figure S1). For example, in the p53 site
associated with the Huntingtin gene, HTT, not only the
core motifs CATG and CTGG but also flanking
sequences are identical to those in the AluSq2 consen-
sus sequence (Figure 2), suggesting that for a substantial
number of the AluSq2 elements interspersed throughout
human genome, the Box B regions could serve as the
‘natural born’ sites for p53 binding.
Third, the two groups of p53 REs differ in the length
of spacer, S. In particular, 80% of the REs mapped at
position 150 (Box A’) have spacer S = 0, whereas for
position 85 (Box B), the fraction of p53 sites with spacer
S = 0 is less than 30% (Figure 2, Table 1).
In summary, the functional p53 REs mapped to Alu
elements can be separated into two groups, character-
ized by distinctive locations in Alu repeats, the density
and mutation rate of CG dimers in the corresponding
Alu regions and the spacer length S. This assessment
based on a limited set of p53 REs is corroborated by a
genome-wide analysis of putative p53 BSs in Alu ele-
ments described in the following sections.
In silico identification of putative p53 sites in human
genome
First, we searched for putative p53 BSs in masked and
unmasked human genome (NCBI Build 36) to understand
how these sites are distributed between the repeat and
non-repeat regions. A scan of the unmasked genome
found ~2 million p53 sites with the PWM-20 scores of
70% or higher (see Methods). Remarkably, distribution of
the spacer lengths in these sites is highly non-uniform,
with the peaks at S = 0, 3, 8 and 14 bp (Figure 3). The
highest occurrence of ~210,000 sites is observed for spacer
S = 0, whereas the background level is ~120,000 sites. The
prevalence of the mentioned spacers disappeared, how-
ever, when the masked genome was used - in this case, the
occurrences of various spacers became nearly equal,
~60,000 sites for each spacer size (Figure 3). This result
implies that the p53 sites with selected spacer sizes men-
tioned above (S = 0, 3, 8 and 14 bp) are overrepresented in
repeats. Overall, the repeat regions of human genome con-
tain ~1.05 million potential p53 sites satisfying the criteria
listed in Methods (data not shown).
Distribution of p53 sites in Alu repeats
A search of putative p53 BSs in Alu repeats using
PWM-20 rendered ~0.4 million BSs (Table 2), or 38%
of the sites found in all repeats. Therefore, consistent
with our findings for the functional p53 REs (see above),
the Alu elements have a (somewhat) higher ‘density’ of
putative p53 sites compared to other repeats. Analysis
of the spacer lengths in the Alu-residing p53 sites also
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human genome. The prevalent spacer lengths are indicated.
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logy with Figure 3, majority of the sites have spacers S =
0, 3, 8 and 14 bp. Comparison between the amplitudes
of the peaks in Figures 3 and 4A indicates that Alu
repeats harbor ~60% of all the sites with these selected
spacers, residing in repeats.
Next, we analyzed positions of potential p53 BSs in Alu
elements (Figure 4B) and found that their distribution
resembles the one derived from the functional p53 REs
(Figure 2). First, note that the p53 sites in Figure 4B are
clustered around the same three positions, 10, 85 and
150, as the three hot spots shown in Figure 2. Second,
the p53 BSs with S = 0 are distributed differently from
those with S ≠ 0. The putative sites with S = 0 occur pre-
dominantly around positions 10 and 150 (Figure 4B),
coinciding with the two hot spots representing group A;
similarly, most of the functional REs positioned here
have spacer S = 0 (Figure 2). By contrast, most of the p53
BSs with S ≠ 0 are found near position 85 (Figure 4B),
overlapping with the hot spot representing group B
(Figure 2). Note that ~70% of the functional REs in
group B also have spacer S ≠ 0.
Spacer distribution in Alu-residing p53 sites correlates
with the age of Alu elements
Further analysis of p53 sites associated with Alu
repeats revealed a strong variability of the Alu subfa-
milies in terms of positioning (and distribution) of p53
BSs with different spacers (Figure 5 and Additional
File 4: Figure S4). Specifically, for the AluSx elements,
the most prevalent spacer is S = 3 (Figure 5A), while
for the AluJo elements, the spacer S = 8 is predomi-
nant (Figure 5B). Comparison of the most frequent
spacer sizes in different Alu subfamilies reveals an
interesting tendency - the spacer length, S, generally
correlates with the age of Alu elements (Table 2). For
example, the ‘old’ Alu subfamilies FLAM-A, FLAM-C
and AluJo are characterized with spacer S = 8; in the
‘intermediate’ subfamilies AluJb, AluSx, AluSq the
Table 2 Summary of p53 motifs found in selected Alu
subfamilies
Name
a # Alu
elements
b
# p53 motifs
c S=0
d S=3
d S=8
d S=1 4
FLAM-A 18264 5484 633 233 2080 1057
FLAM-C 35888 14083 1786 804 5036 3923
AluJo 137954 75938 13745 4424 20989 14007
AluJb 126856 62528 12542 11954 4297 9560
AluSx 333710 129530 32361 42879 8104 16192
AluSq 93874 30593 7253 12164 409 4445
AluSg 84797 30561 9593 6280 3608 3136
AluSp 50857 21429 13340 1904 127 2036
AluSc 43135 6884 2945 864 293 92
AluSg1 6130 4429 3570 72 186 200
AluY
e 139813 12488 1753 512 2542 360
Total 1071278 393947 99521 82090 47671 55008
a The Alu subfamilies are ordered by age [80-82,73]. Only subfamilies with the
number of p53 motifs exceeding 4000 are presented.
b The Alu elements are collected from AluGene database [65].
c The p53 motifs with the spacer, S = 0-14 bp, and with PWM-20 scores ≥ 70%
are counted.
d The numbers of p53 motifs with spacer S = 0, 3, 8, 14 bp are presented. For
each subfamily (except AluY), the data corresponding to the prevalent spacers
S are highlighted in boldface and underlined.
e For the AluY subfamily, the prevalent spacer is S = 2 with 4588 p53 motifs
(Additional File 4: Figure S4-I).
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Page 7 of 20spacer is S = 3, while the ‘relatively young’ subfamilies
AluSg, AluSp, AluSc and AluSg1 have the shortest
possible spacer S = 0. From the evolutionary stand-
point, this trend can be interpreted as an increase in
the p53 binding affinity in the younger Alu elements
(because the p53 tetramer is known to bind stronger
to the sites with shorter spacers [5,6]).
Note that in those subfamilies where the predominant
spacer is S = 3 or 8, the p53 sites are mostly located
near position 85 (Box B, Figure 6 and Additional File 4:
Figure S4), which is entirely consistent with the global
picture shown in Figure 4B. When the most frequent
spacer is S = 0, the corresponding p53 sites are distribu-
ted between all the three hot spots 10, 85 and 150 - see
AluSg, AluSp, AluSc and AluSg1 in Figure 6 and Addi-
tional File 4: Figure S4. (In the subfamilies AluSp and
AluSc the p53 BSs with zero spacer length occur at
positions 10 and 150; in AluSg these p53 BSs are found
at positions 10, 85 and 150; in AluSg1 nearly all p53
BSs are located at position 85.)
The exception is the youngest subfamily AluY with pre-
dominant spacer S = 2 and the p53 sites located mostly
around position 215 (Additional File 4: Figure S4-I). How-
ever, all these families with spacer S = 0 or 2 contain rela-
tively small number of puta t i v ep 5 3B S s( T a b l e2 )a n d
these BSs do not change the general statistics presented in
Figure 4.
Distinctive chromatin context of putative p53 sites
embedded in Alu repeats
Earlier, Howard and his colleagues [37,38] found that Alu
elements can harbor two nucleosomes: one resides within
the right Alu monomer, between the inter-monomer
A/T-rich spacer and 3’ poly(dA) tract (Figure 7A); the
other nucleosome partially overlaps with the left mono-
mer so that its center is located around the 5’ end of the
Alu repeat. Recent analysis of the genome-wide nucleo-
some occurrences confirmed this observation [44]. As a
consequence, the p53 BSs clustered around position 85
(and characterized by spacer S ≠ 0) are located in the
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Page 8 of 20nucleosome-free linker region (Figure 7A). Therefore,
they are likely to be easily accessible for p53 binding.
By contrast, the p53 BSs with spacer S = 0 mapped
at positions 10 and 150 are embedded in nucleosomes
(Figure 7A). In this case, the p53 binding to its cog-
nate site would depend on the rotational orientation
of the site with regard to the histone octamer. Based
on the results of stereochemical analysis and gel elec-
trophoresis data, we predicted that if the p53 site is
properly exposed on the nucleosomal surface and bent
into the minor groove in the center of 20-meric motif
(Figures 1 and 7B), the p53 tetramer would have a
high affinity to such site [45,46]. If, however, the p53
site is positioned in nucleosome in the opposite rota-
tional orientation, the p53 binding would be highly
unfavorable (practically impossible without unraveling
nucleosomal DNA) due to steric hindrances imposed
by the core histones. Recent experiments confirmed
this prediction [39].
We are particularly interested in analyzing rotational
orientation of the p53 BSs mapped to position 150 and
embedded in the ‘right’ nucleosome (Figure 7A). This
nucleosome covers the right Alu monomer and is loca-
lized between two long A-tracts at positions ~120/
~135 and ~280/~290. Thus, its location is strongly
restricted and (almost) does not depend on the neigh-
boring genomic DNA. In other words, the ‘right’
nucleosome detected by Englander and Howard [37] in
the AFP-Alu element and similarly positioned nucleo-
somes in other Alu repeats are probably the most
representative in human genome, covering ~5% of all
DNA (because the Alu repeats comprise ~10% of gen-
ome, and the ‘right’ nucleosome covers one half of Alu
repeat).
To determine the most favorable rotational position-
ing of the ‘right’ nucleosome, we used a theoretical
approach [47] based on the well-known sequence pat-
tern in nucleosomal DNA - the AT-rich dimers prefer-
entially occur at the sites of DNA bending into the
minor groove, while the GC-rich fragments occur at the
sites where DNA is bent toward the major groove. (For
details see Set 1 in Table SIII [47]). We found that the
rotational orientation of DNA with regard to the histone
octamer is optimal when the nucleosome dyad is located
at position 207 - that is, just in the center of the 147-bp
fragment (positions 134 to 280) between two A-tracts
(Figure 7A).
In this case, DNA in position 150 is bent into the
minor groove and the p53 site with its center in this
position has a conformation remarkably similar to that
induced by p53 binding (Figure 7B). In particular, the
two core CNNG tetramers are bent into the major
groove (the red balls in Figure 7B), whereas the junc-
tion between two half-sites is bent into the minor
groove (the blue balls in Figure 7B). The strong resem-
blance between these two DNA conformations suggests
that the p53 site embedded in nucleosome can be
accessible for p53 binding. This assertion is consistent
with recent experiments indicating that p53 tetramer
effectively binds its cognate site wrapped in nucleo-
s o m ei ft h es i t ei sp r o p e r l ye x p o s e do nt h en u c l e o s o -
mal surface [39].
Based on these observations, we conclude that the two
groups of potential p53 sites residing in Alu elements
are likely to have distinctive chromatin environment.
The sites with spacer S ≠ 0 (position 85) are located in
the inter-nucleosome linker regions, while the sites with
spacer S = 0 (position 150) are exposed on nucleosomes.
Box A Box B
RGYNNRRYGG
||||||||||
FLAM_A –GCCGGGCGCGGTGGCGCGCGCCTGTAGTC
FLAM_C RGCCGGGCGCGGTGGCTCACGCCTGTAATC
AluJo  GGCCGGGCGCGGTGGCTCACGCCTGTAATC  
AluJb  GGCCGGGCGCGGTGGCTCACGCCTGTAATC 
Al S GGCCGGGCGCGGTGGCTCACGCCTGTAATC
Box A’
RGYNNRRYGG
||||||||||
TTAGCCGGGCGTGGTGGCGCGCGCCTGTAGT AluJo
TTAGCCGGGCGTGGTGGCGCGCGCCTGTAGT AluJb
TTAGCCGGGCGTGGTGGCGCGCGCCTGTAAT Al S
GWTCRANNCC
||||||||||
CCCAGGAGTTCGAGACCAGCCTGGGCAACATAGCGAGACCCCGTCT
CCCAGGAGTTCGAGACCAGCCTGGGCAACATAGCGAGACCCCGTCT
CCCAGGAGTTCGAGACCAGCCTGGGCAACATAGCGAGACCCCGTCT
CCCAGGAGTTCGAGACCAGCCTGGGCAACATGGTGAAACCCCGTCT
GTCAGGAGTTCGAGACCAGCCTGGCCAACATGGTGAAACCCCGTCT AluSx GGCCGGGCGCGGTGGCTCACGCCTGTAATC
AluSq  GGCCGGGCGCGGTGGCTCACGCCTGTAATC 
AluSg  GGCCGGGCGCGGTGGCTCACGCCTGTAATC 
AluSp  GGCCGGGCGCGGTGGCTCACGCCTGTAATC
AluSc  GGCCGGGCGCGGTGGCTCACGCCTGTAATC 
AluSg1 RGCCGGGCGCGGTGGCTCACGCCTGTAATC 
AluY GGCCGGGCGCGGTGGCTCACGCCTGTAATC
TTAGCCGGGCGTGGTGGCGCGCGCCTGTAAT AluSx
TTAGCCGGGCGTGGTGGCGGGCGCCTGTAAT AluSq
TTAGCCGGGCGTGGTGGCGCGCGCCTGTAAT AluSg
TTAGCCGGGCGTGGTGGCGCATGCCTGTAAT AluSp
TTAGCTGGGCGTGGTGGCGCGCGCCTGTAGT AluSc
TTAGCCGGGCGTGGTGGCGCGGGCCTGTAAT AluSg1
TTAGCCGGGCGTGGTGGCGGGCGCCTGTAGT AluY
GTCAGGAGTTCGAGACCAGCCTGGCCAACATGGTGAAACCCCGTCT
GTCAGGAGTTCGAGACCAGCCTGGCCAACATGGTGAAACCCCGTCT
GTCAGGAGTTCGAGACCAGCCTGGCCAACATGGTGAAACCCCGTCT
GTCGGGAGTTCGAGACCAGCCTGACCAACATGGAGAAACCCCGTCT
GTCAAGAGATCGAGACCATCCTGGCCAACATGGTGAAACCCCGTCT 
GTCAGGAGTTCGAGACCAGCCTGGCCAAGATGGTGAAACCCCGTCT 
GTCAGGAGATCGAGACCATCCTGGCTAACACGGTGAAACCCCGTCT AluY   GGCCGGGCGCGGTGGCTCACGCCTGTAATC
1        10        20       30 
TTAGCCGGGCGTGGTGGCGGGCGCCTGTAGT AluY
140       150       160     
GTCAGGAGATCGAGACCATCCTGGCTAACACGGTGAAACCCCGTCT
70        80        90        100       110   
S=0 S=0 S=3 S=8 S=14
Figure 6 Localization of putative p53 sites with selected spacer lengths in the Alu elements. The scheme summarizes the data presented
in Figures 5 and S4 (Additional File 4). The consensus sequences of 11 Alu subfamilies were downloaded from Repbase Update [74-76] and
aligned using the ClustalW module in BioEdit [77]. Top: The consensus sequences of the Boxes A, B and A’ [78] are aligned with the Alu
sequences. The CNNG core motifs shown in color indicate predominant positions in the Alu elements where the p53 sites were found. For each
Alu subfamily, the distances between the CNNG cores in the consensus sequence are directly related to the predominant spacer lengths
observed in the p53 sites residing in the corresponding Alu repeat (Figures 5 and Additional File 4: Figure S4). In the case of AluY subfamily,
most of the p53 sites are located around position 215 and have spacer S = 2 (Additional File 4: Figure S4-I). The color code corresponds to the
spacer length: red for S = 0, blue for S = 3, green for S = 8 and yellow for S = 14 bp.
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Page 9 of 20In both cases, the p53 sites are expected to be accessible
for p53 binding.
Discussion
Significant number of putative p53 sites in human
genome
The number of p53 binding sites in human genome
has been estimated based on experimental data. For
example, 37 sites were identified in 1% of human
genome (ENCODE) using ChIP assays, which can be
extrapolated to ~3,700 sites genome-wide [48]. Analysis
of the ChIP assay on human chromosomes 21 and 22
(~3% of genome) revealed 48 binding sites, which can
be extrapolated to ~1,500 sites in the whole genome
[49]. Two recent genome-wide ChIP experiments
detected ~65,000 low-confidence p53 sites [7] and
~1,500 high-confidence sites [8].
The studies using various bioinformatics approaches
found the larger numbers of p53 sites. In particular, the
algorithm based on the p53 affinity for DNA binding
S=0 S=0 S0 A
dyad
(207)
280 120 135
150 85
Alu B A A’
10
1
120       130    140 150 160       170
|         |     | | |         |
dyad (207)
AAAAAATACAAAAATTAGCCGGGCGTGGTGGCGCGCGCCTGTAGTCCCAGC
B dyad (207)
150
(M)
150
(m)
(M)
Figure 7 Experimentally mapped nucleosomes and predicted p53 BSs in Alu elements.( A )T h et w om a p p e dn u c l e o s o m e s( m a g e n t a
ellipses) are shown together with the three clusters of p53 sites near positions 10 (Box A), 85 (Box B) and 150 (Box A’). For each cluster, the
prevalent spacer S is indicated (Figures 2 and 4). The fragment of Alu consensus sequence is presented (positions 120 to 170), with the 20 bp-
long counterpart of the predicted p53 site colored in red and blue. The underlined dimers correspond to the base pairs shown as the red and
blue balls in the left part of Figure 7B. The approximate in vitro nucleosome position in the right Alu monomer has been established by
Englander and Howard [37]. The shown dyad position 207 corresponds to the optimal rotational setting of this nucleosome - see main text. (B)
Exposure of the p53 site embedded in the nucleosome mapped on the right Alu monomer (covering the interval from 134 to 280). Right: The
histone octamer is shown as a cylinder and DNA is represented by ribbons (sugar-phosphate backbone) and balls (centers of base pairs). The
blue balls indicate the dimeric steps where DNA is bent into the minor groove [79]. For the ‘posterior’ half of nucleosome, the DNA axis is
represented by grey sticks. Left: The p53-DNA complex (Figure 1) is shown schematically with four ellipses representing the p53 tetramer bound
to a 20-bp DNA fragment (spacer S = 0). The DNA axis is represented by sticks and balls. The red balls stand for the centers of the CNNG core
motifs bent into the major groove, and the blue ones for the junction between two half-sites bent into the minor groove (underlined in Figure
7A). Note that conformation of the DNA fragment bound by p53 tetramer (on the left) closely resembles conformation of the 20 bp-long
fragment of nucleosomal DNA centered at position 150 (on the right). Therefore, the p53 site embedded in nucleosome at this position is likely
to be accessible for p53 binding. Centers of the other accessible sites are shown by blue balls.
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200,000 weaker ones with spacer S = 0-1 [50]. A gen-
ome-wide search of the p53 binding motifs consisting of
two half-sites RRRCWWGYYY with spacer S = 0 found
~160,000 sites [36]. Using a standard PWM-based
approach that allows the spacer S to vary from 0 to 14
bp (see Methods), we found approximately two million
putative p53 BSs in human genome (ref. [13] and this
study). Note that we used 70% cutoff for the PWM
score, corresponding to the vast majority of the func-
tional p53 REs (Additional File 5: Figure S3). Although
some sites in our list may not be accessible to p53 in
chromatin (which is known to be tissue-specific), our
data indicate that the number of potential p53 BSs
could be several orders of magnitude higher than the
number of sites observed in ChIP assays.
Two distinctive origins of p53 sites in Alu repeats
A significant number of the p53 BSs detected in gen-
ome-wide ChIP experiments [7] have been shown to
reside in various repeat subfamilies such as ERV LTRs
[14] and Alu repeats [36]. This observation posed the
question on how these sites evolved - did they exist in
the progenitors of the mentioned repeats, or did they
arise by mutations?
By analyzing the LTR consensus sequences of the six
ERV subfamilies containing p53 sites and comparing
them with the subfamilies without p53 sites, Haussler
and his colleagues [14] concluded that the p53 sites prob-
ably were embedded in the founders of these ERV subfa-
milies. On the other hand, Vingron and coworkers [36]
applied the same strategy by comparing the p53 BSs with
the consensus sequences of different Alu subfamilies.
They found that the Alu counterparts of the p53 binding
motifs contain the CG dimers in the positions corre-
sponding to CA and TG in the p53 sites. Therefore, they
suggested that the p53 sites with the CATG core motif
could be generated by mutations, namely, through
methylation and deamination of CpG [36].
Our analysis of the functional p53 REs showed that in
two out of three locations where the p53 REs are
mapped on Alu repeats (around positions 10 and 150,
Boxes A/A’), the CG dimer occurs frequently in the Alu
regions corresponding to the p53 core motif, implying
that CG ® TG mutations could give birth to p53 sites,
as proposed earlier [15,36]. By contrast, in the other
location (around position 85, Box B), the CG dimer is
rarely found in the corresponding region of Alu
sequences. Moreover, the p53 site associated with the
Huntingtin gene (HTT) aligns perfectly well with the
AluSq2 consensus sequence, so that there are no mis-
matches in the core regions (Figure 2 and Additional
File 2: Figure S1), which indicates that this site probably
pre-existed in the progenitors of at least some Alu
subfamilies (see Box B in Figure 6). Therefore, in our
opinion, the p53 sites residing in Alu repeats could be
generated by both mechanisms discussed above [14,36].
Implications for the repression of Alu transcription by
p53
Previous studies showed that p53 can represses pol III
transcription through interaction between the p53 N-
terminal domain and TFIIIB, a factor containing
TATA-binding protein [51-53]. In addition, the DNA
binding domain (DBD) of p53 was also found to be
critical for the transcriptional repression [54]. Based
on the observation that the hot spot around position
85 is close to Box B of the pol III promoter (Figures 2
and 6), we can suggest a simple mechanism for the
p53-induced repression of Alu transcription. Given
that the p53 DBD is required for Alu silencing [54], it
is plausible that p53 binds to this site in vivo;a sac o n -
sequence, the N-terminal region of p53 would directly
interact with TFIIIB, thereby precluding effective
assembly of the pol III transcription machinery. There-
fore, mutations in p53 leading to defects in DNA bind-
ing would result in pol III hyperactivity that is
characteristic of many tumors [52,55]. In particular,
there is direct evidence of the increased level of Alu
RNA in hepatocellular carcinoma [56].
Moreover, we hypothesize that the p53 binding to Alu
elements and repression of their transcription can
change the expression of the host genes. This potential
effect is related to the steric interaction between the pol
II and pol III machineries, which, in turn, depends on
the direction of Alu transcription (pol III) relative to
the host gene transcription (pol II). If the two poly-
merases are moving in the opposite directions, one
would expect that the head-on collision would slow
down both of them, by analogy with the collision
between the DNA replication apparatus and RNA poly-
merases [57]. (At least in one case [58] it is shown that
pol II transcription from the upstream promoter of the
human ε-globin gene is effectively blocked by pol III
transcription of the Alu element from the opposite
DNA strand.) If, however, the two RNA polymerases
are moving co-directionally, the sterical hindrance
between them is unlikely. (In principle, pol III transcrip-
tion may even facilitate the pol II processing through
chromatin.) Thus, upon p53 binding to Alu elements,
the genes containing Alu inserts would be regulated dif-
ferently. Those genes, whose transcription goes in the
direction opposite to the transcription of the Alu
inserts, are likely to be activated by p53. In the alterna-
tive case, when the Alu and the host gene transcriptions
are co-directional, we predict either no effect upon p53
binding, or a relatively insignificant p53-induced trans-
repression.
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tion on the expression of the host genes may be one of
the selective factors responsible for the frequent occur-
rence of Alu repeats in introns of human genes.
Conclusions
We observed that 24 out of ~160 known functional p53
REs reside in repeats and more than half of the repeat-
associated REs occur in Alu elements. These REs can be
further divided into two groups depending on their
proximity to Boxes A/A’ or Box B of the pol III promo-
ter (Figure 1). Most of the REs overlapping with the A/
A’ boxes have zero length spacer. A comparison of the
REs and the Alu subfamily consensus sequences showed
that the CG dimers frequently occur at positions corre-
sponding to the CA:TG dimers in the p53 core motifs,
indicating that these sites could be generated by methy-
lation and deamination of CpG, as was proposed by
Zemojtel et al. [36].
On the other hand, the majority of the REs located
close to the B box have spacer S ≠ 0. The CG dimers
rarely occur in the corresponding Alu regions, suggest-
ing that the CG ® TG transition was not critical for
generation of these sites. Rather, they might be present
in the progenitors of at least several Alu subfamilies.
Thus, we conclude that the p53 binding sites residing in
Alu elements likely evolved by both of the mechanisms
proposed earlier [14,36].
Analysis of potential p53 BSs embedded in Alu ele-
ments genome-wide showed that the BSs are distributed
in a pattern similar to the functional REs discussed
above (Figure 4). The similarity between the putative
p53 BSs and the functional REs indicate that many of
these BSs could be bound by p53 in vivo. In addition,
the S spacers are distributed in a subfamily-specific
manner and correlate with the Alu age: in general, the
younger subfamilies are characterized by shorter spacer
lengths (Table 2). It is tempting to speculate that the
observed tendency could be related to the increased p53
binding affinity to its cognate binding sites in the
‘younger’ Alu elements. (This is because p53 binds to
the sites with S = 0 stronger than to the sites with other
spacer lengths [5,6].)
Note in this regard that the ‘younger’ Alu elements are
characterized by a decreased binding affinity to proteins
SRP9/14, comprising a part of the signal recognition
particle (SRP) [59]. According to the hypothesis pro-
posed by Bennett et al. [59], modern Alu RNAs have
developed the ability to disengage from SRP9/14 more
readily during reverse transcription, which, in turn, may
be advantageous for Alu retrotransposition.
By analogy, here we speculate that evolution of Alu
repeats (that is, several waves of Alu expansion) might
be influenced by interactions with p53. We suggest that
under selective pressure, the recent Alu elements
mutated in such a way as to strengthen p53 binding and
increase the level of the p53-induced repression of Alu
transcription (see above). Keeping Alu expression below
a certain level is critical both for the host and for trans-
posable repeats, because excessive Alu transcription
would be too exhaustive for the host cell (and even-
tually, disadvantageous for Alu as well).
Following this scenario, invasion of a ‘young’ Alu ele-
ment (with a low level of pol III transcription) in the
vicinity of a gene promoter, would not disturb pol II
transcription of the gene itself. In this way, the p53 BS
with a short spacer (S = 0 or 3 bp) and relatively strong
p53 binding, would be easily transposed close to the
transcription start site, thereby creating (or modifying)
the network of p53-dependent regulation of this gene.
Finally, we wish to emphasize that the two groups of
p53 REs and BSs (located close to the A/A’ or B boxes
in Alu repeats) are likely to have different chromatin
environments, which are critical for p53 binding
[10,39,46]. This observation suggests new criteria for
selecting the ‘strong’ functional p53 sites (which may
have been instrumental in evolution). In addition to the
widely used various PWM-scores (measuring the level of
similarity between the putative binding site and the con-
sensus template), one can estimate the strength of a
nucleosome-forming signal and the rotational position-
ing of the p53 site in the nucleosome fold. We antici-
pate that by applying this approach to genome-wide
scanning of all possible p53 sites, we will be able to
select only those sites which are ‘properly exposed’ in
nucleosomes (Figure 7). One of the major problems in
genome-wide analysis is the huge number of ‘non-func-
tional’ p53 binding sites. We hope that by using this
novel ‘filtering’ technique we will be able to reduce the
list of potential p53 REs.
Methods
Identification of functional human p53 response elements
occurring in repeats
The largest collection of p53 REs published recently by
Riley et al. [6] comprises 156 sites. Note, however, that
a p53 site from human hepatitis B virus (HBV) and two
identical sites from the gene COL18A1 were included in
this dataset. We removed the HBV site and one dupli-
cate site of COL18A1 gene from this list. On the other
hand, four p53 REs were detected experimentally in the
CASP10 promoter [60], whereas only one of them was
considered by Riley et al.[ 6 ] .T h e r e f o r e ,w ea d d e dt h e
other three CASP10 sites to the dataset. As a result, we
obtained the list of 157 functional p53 REs, which was
used in this study.
The selected p53 REs were extended on both sides by
250 bp flanking sequences extracted from human
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aligned with repeats using RepeatMasker (A.F.A. Smit,
R. Hubley, and P. Green, http://www.repeatmasker.org)
and CENSOR [61]. The p53 REs overlapping with
repeats by at least 5 bp are shown in Table 1 (see Addi-
tional File 2: Figure S1 and Additional file 3: Figure S2
for details).
Construction of the position weight matrix to predict
putative p53 binding sites
To find putative p53 BSs in human genome, we used a
standard position weight matrix approach, PWM-20 [4],
based on 34 experimentally validated p53 REs (Addi-
tional File 1: Tables S2 and S3). (The index 20 reflects
the fact that a ‘canonical’ p53 BS contains two decamers
RRRCWWGYYY.)
Later, the wider sets of p53 REs were collected,
including a comprehensive collection of 157 sites men-
tioned above [6]. We decided, however, not to update
our PWM-20, mostly for the two reasons. First, as the
number of p53 REs increased fourfold (from 34 to 156),
the number of the sites with ‘broken’ core motif CNNG
increased about sevenfold, from 6 to 40 (data not
s h o w n ) .( T h ec o r em o t i fC N N Gi nt h ec e n t e ro fe a c h
p53 half-site is critical for rigorous p53-DNA recogni-
tion through formation of the arginine-guanine hydro-
gen bonds in the major groove [62,63].) In other words,
the statistical requirements imposed on the p53 sites
based on the Riley’s dataset [6] are more lenient (com-
pared to PWM-20), which would greatly increase the
number of ‘false-positive’ p53 BSs found in genome.
Second, in the previous study [4] a 70% cutoff for the
PWM-20 score was determined based on the score distri-
bution for the functional REs used to build PWM-20
(Additional File 1: Table S3). Calculation of the PWM-20
scores for the Riley’s dataset [6] and for ~1,100 p53 BSs
detected in vivo by Smeenk et al. [8] confirms that 70% is
a ‘natural’ cutoff value (Additional File 5: Figure S3).
The process of generating PWM-20 score includes
two stages. First, each potential site is characterized by
the ‘raw’ score - the sum of the weight matrix elements
representing occurrences of the individual bases (or
dimers) at each position, see Table S2 in Additional File
1. The score is then represented in percent, 100% corre-
sponding to the best possible BS and 0% corresponding
t ot h ew o r s tp o s s i b l eB S .T h ec u t o f fv a l u e7 0 %( A d d i -
tional File 5: Figure S3,) means that any site with PWM-
20 score exceeding 70% is considered to be a putative
p53 BS.
Our PWM-20 differs from the published PWM-based
approaches used for p53 BS prediction [7,64] in several
important aspects. First, PWM-20 is a symmetric weight
matrix - that is, the score calculated for any sequence is
identical to the score for its reverse complement. This
requirement naturally follows from the symmetry of the
DNA-bound p53 tetramer [62,63]. Second, PWM-20 uti-
lizes dimeric frequencies for the positions 5-6 and 15-16
in the centers of decamers RRRCWWGYYY (Additional
File 1: Table S2), reflecting the fact that the dimers AT
and AA:TT are predominant, while the dimers TA, SW
and WS are extremely under-represented in these posi-
t i o n s( Wi sAo rT ,Si sGo rC ) .T h i r d ,P W M - 2 0i s
based entirely on the functional p53 REs (34 in vivo REs
used for PWM-20 compared to 37 in vitro BSs used by
Hoh et al. [64].)
Collection of Alu elements in human genome
Alu elements (~1.1 million in total) were downloaded
from AluGene Database [65]. The elements were sepa-
rated into different subfamilies (Jo, Jb, Sx, etc.) based on
the notations provided by the database.
Reviewers’ comments
Reviewer 1: Igor B. Rogozin (nominated by Pavel Pevzner)
The authors suggested that the primate-specific Alu
repeats play an important role in shaping the p53 regula-
tory network in the context of chromatin. This conclu-
sion is based on analysis of experimentally confirmed and
computationally predicted p53 binding sites. The authors
analyzed 160 functional p53 response elements and
found that 24 of them occur in repeats. More than half of
these repeat-associated response elements reside in Alu
elements. This means that ~10% of experimentally veri-
fied p53 response elements are located in Alu elements.
This number perfectly coincides with the fraction of Alu
elements in the human genome which is ~11%. Thus
there is no elevated frequency of p53 response elements
in Alu elements. This may be due to a small number of
experimentally confirmed p53 response elements. Unfor-
tunately, the authors did not try to analyze recent gen-
ome-wide ChIP experiments [7,8].
Authors’ response: Yes, there is no elevated fre-
quency of p53 response elements (RE) in Alu ele-
ments, but the number of well established functional
p53 REs, 160, is probably too small to make final
conclusions. On the other hand, the number of pre-
dicted (putative) p53 sites has a higher density than
the rest of genome (see below our response to the
second fragment of I.B. Rogozin’s review).
As to the ChIP experiments, its analysis would not
improve the above statistics, because the ChIP data
provide information about the p53 binding sites
(BS), both functional and non-functional.
There are several reasons why we did not analyze
the ChIP DNA fragments. First, it has been done by
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the available p53 ChIP fragment sets [7,8] are
incomplete, with most of the detected p53 BSs posi-
tioned far away from the transcription start sites
(Additional File 1: Table S1). Third, as was reported
at the 15-th International p53 Workshop (October
2010, Philadelphia, USA), several groups are currently
preparing more exhaustive p53 ChIP datasets,
obtained for various types of normal and cancer cells.
In addition, there is a principal limitation of the
ChIP technology with regard to detecting all func-
tional p53 sites in the repeating elements such as
Alu. The ChIP-seq method is based on sequencing
the short ‘reads’ at the ends of the p53-bound DNA
fragments (several hundred base pairs in length)
with subsequent mapping of these ‘reads’ to human
genome. If the unique mapping is impossible, the
p53-bound DNA fragment is typically ignored. In
the case of Alu repeats having a high degree of
homology, the probability of occurrence of numer-
ous identical ‘reads’ is rather high. As a conse-
quence, many ‘real’ p53 BSs belonging to Alu
repeats are missed. As far as the repeating elements
are concerned, the p53 ChIP datasets will remain
incomplete unless the ChIP-seq methodology is
improved (e.g., the length of DNA ‘reads’ is
increased). Therefore, in our opinion, the detailed
theoretical analysis of the p53 ChIP data would be
much more productive one or two years from now.
Using a position weight matrix approach, the authors
found ~400,000 potential p53 binding sites in Alu ele-
ments genome-wide. Using the previous estimate (~10%
of p53 RE are in Alu) we could easily calculate that the
total number of potential binding sites in the human
genome is ~ 4 million sites. I think that this is too gen-
erous estimate. Therefore, the vast majority of these
potential binding sites are likely to be an over-prediction
which is expected taking into account that the p53 con-
sensus sequence is highly degenerate (see the Introduc-
tion). In addition, the cumulative work obtained from
different laboratories suggests that p53 is not a stand-
alone protein; rather, it participates in a complex net-
work of proteins working in concert [66-68]. Therefore,
even for a good binding site there is no guarantee that
it will influence transcription of neighboring genes.
Authors’ response: We agree that the above esti-
mate of ~4 million p53 sites is too generous. In fact,
we calculated the number of p53 BSs directly:
“A scan of the unmasked genome found ~2 million
p53 sites with the PWM-20 scores of 70% or higher”
(Results, page 8). This means that the p53 BSs are
over-represented in Alu repeats (compared to the
rest of genome, including the other, non-Alu
repeats). See also on page 8: “the Alu elements have
a( s o m e w h a t )h i g h e r‘density’ of putative p53 sites
compared to other repeats.”
In any case, there is no doubt that some of these
potential elements are functional and they might influ-
ence the transcription of neighboring genes immediately
after insertion of a new copy of Alu. Although we do
not know the number of such case, this possibility poses
an interesting question about how primates tolerated a
load of p53 binding sites in their genomes. I think that
some insertions are deleterious (likely to be removed by
purifying selection) and some insertions of Alu together
with p53 binding sites may be utilized. This point rever-
berates with the classical paper of Wojciech Makalowski
[69] I will use direct quotes from the abstract of this
paper:
“Interspersed repetitive sequences are major compo-
nents of eukaryotic genomes. ... they are often quoted as
a selfish or junk DNA. Our view of the entire phenom-
enon of repetitive elements has to now be revised in the
light of data on their biology and evolution.... I would
like to argue that even if we cannot define the specific
function of these elements, we still can show that they
are not useless pieces of the genomes. The repetitive
elements interact with the surrounding sequences and
nearby genes. They may ... acquire specific cellular func-
tions such as RNA transcription control or even become
part of protein coding regions. Finally, they provide very
efficient mechanism for genomic shuffling. As such,
repetitive elements should be called genomic scrap yard
rather than junk DNA.”
The p53 binding sites nicely fit this concept taking
into account that the rate of turnover of these elements
is known to be high [70]. In general, transcription factor
binding sites are frequently lost and gained [71]. Thus I
expect that many potential binding sites have been
s p r e a d i n gb ym o b i l ee l e m e n t s ,h o w e v e ro n l yas m a l l
fraction of these elements have been used as functional
regulatory signals.
Reviewer 2: Sandor Pongor
Tumor suppressor p53 is unique in the sense that it reg-
ulates over a thousand human genes. p53 is known to
bind to a cognate site consisting of two decameric half
sites separated by a spacer. Recently it has been found
that many of the sites that bind p53 in vivo are within
transposable elements. One should note that in vivo
binding sites (BSs) are not necessarily functional p53
response elements (REs). The interesting study of Cui
and associates asks the question whether or not REs
also reside in transposable elements, particularly Alu
repeats. The authors find that BSs are located in the
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vicinity of A/A’ and B boxes of the internal RNA poly-
merase III promoter. The authors conclude that Alu
residing p53 sites may have evolved through a mechan-
ism that is different from that of the corresponding Alu
consensus sequences and suggest that the strongest
binding sites are embedded in the young Alu repeats.
My questions are:
a) Can one estimate the background probability of
occurrence of the motifs tested? In other words, can
one assign a statistical significance to the findings?
Authors’ response: To evaluate the significance of our
findings, compare the peaks in Figures 3, 4 with the
background. For Figure 3, the average for the peaks at
S = 0, 3, 8, 14 is 182,587 (filled circles). The average
and RMSD (s) for the background are 121,135 and
9,883 respectively. (The occurrences of the spacer
lengths are averaged for S varying from 1 to 13,
excluding the four peaks mentioned above.) Thus, the
difference between the ‘peaks’ and the background
equals 6.22 × s (6.22 = (182587 × 121135)/9883).
For Figure 4A, the average for the four peaks is 71,885,
while the average and RMSD for the background are
10,141 and 4,234 respectively. In this case, the differ-
ence between the ‘peaks’ and the background equals
14.58 × s (14.58 = (71885 - 10141)/4234). From
the Student t-test http://studentsttest.com, we have
p<1 0
-6 for both cases.
b) At the first glance the periodicity of occurrence vs.
spacer length on Figure 3, 4, 5 falls close to half of B-DNA
periodicity that may be correlated with the sidedness of a
recognition site - is the periodicity statistically insignificant?
Authors’ response: The peaks of occurrence corre-
sponding to spacer S = 0, 3, 8 and 14 bp are statisti-
cally significant (see above). The differences between
these S values are 3, 5 and 6 bp. Indeed, 5 and 6 are
close to 10.5/2. How can one interpret this?
The Alu elements originated from the 7SL RNA,
which is a part of the Signal Recognition Particle (SRP)
[59]. Therefore, the occurrence of p53 sites with cer-
tain spacer S is the consequence of the 7SL RNA
sequence organization: the tetramers in Box B at posi-
tions ~100 to ~110 (shown in blue, green and ochre in
Figure 6), are separated by 1 and 2 bp (which corre-
sponds to the shifts of 5 and 6 bp respectively). To
find if this has any structural meaning, one has to ana-
lyze the crystal structures of the SRP, which contains
7SL RNA and several proteins [59]. We are afraid that
any analysis of this kind would be based on numerous
assumptions and thus would be quite speculative.
Reviewer 3: King Jordan
General comments
Feng Cui et al.r e p o r to na na n a l y s i so fA l ue l e m e n t
derived p53 binding sites in the human genome. Trans-
posable element (TE) derived p53 binding sites, and
Alu-derived sites in particular, have been treated at
some length previously both by the group of Victor
Zhurkin, who originally discovered that numerous p53
binding sites are found in TE sequences, and others
such as the Haussler and Vingron groups [14,36]. So
presumably one challenge for the authors was to come
up with a novel angle for this fairly well studied system,
and this was achieved by partitioning p53 binding sites
in to distinct sets for subsequent study. The authors
divided p53 binding sites into three different classes,
each of which differ with respect to the mode of analysis
employed for their detection. First, there are p53 bind-
ing sites that are predicted based on sequence motifs.
The regulatory function, and even the p53 binding affi-
nity, of these sites are largely unknown. Second, there
are p53 ChIP fragments - DNA sequence intervals
experimentally characterized to be bound by p53 gen-
ome-wide. These sites are defined as being bound by
p53 but their regulatory function is unknown. And
finally, there are p53 response elements - DNA frag-
ments that are bound by p53 and also experimentally
characterized to have some regulatory effect, usually on
a reporter gene construct. The work in this study is
focused on what the authors refer to as the ‘extreme
sets’ of p53 binding sites: ~2 million predicted p53 bind-
ing sites genome-wide, for which there is no experimen-
tal evidence of actual binding or regulatory function,
and a far more restricted set of ~160 response elements
with experimentally characterized binding and regula-
tory activities. While I can follow the logic of this
dichotomy, I was never quite clear on why the ChIP
DNA fragment set was not analyzed as well. In any case,
this [is] an extremely interesting manuscript that should
prove to be of broad interest. Accordingly, I do not hesi-
tate to recommend publication of this work in Biology
Direct. I do however have a number of comments on
the analysis and interpretation of the data.
Authors’ response: First of all, we are sincerely
grateful to I. K. Jordan for the detailed and thought-
f u lr e v i e w .T h er e a s o n sw h yw ed i dn o ta n a l y z et h e
ChIP DNA fragments are given in our response to I.
B. Rogozin’s review (see above).
Major points One of the most interesting findings in
this study is based on results showing that there are two
classes of p53 binding sites in Alus: a class that appears
to be derived from methylation and deamination of
CpG sites as previously reported by Vingron and
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been present in ancestral Alus as has been proposed for
LTR-derived p53 sites by the Haussler group [14]. I am
slightly confused about one observation regarding these
two mechanisms. The sites derived from methylation
and deamination map to the region of the element that
is enriched for zero length spacers, which in turn are
over-represented in young Alu elements. How is it that
the youngest elements have experienced more CpG
methylation and deamination than the older elements
that have had many more millions of years to accumu-
late such mutations?
Authors’ response: I.K. Jordan made an interesting
point by linking our observation of the progressive
decrease in the length spacer (in the p53 BSs) with
the existence of two different mechanisms involved
in generation of p53 sites in Alu elements.
We disagree, however, with the reviewer’ assessment:
“The sites derived from methylation and deamina-
tion map to the region of the element that is
enriched for zero length spacers” (that is, to the
regions around the Boxes A/A’). Below, we show
that:
(1) not all sites with S = 0 originated through
CpG mutations (in the Boxes A/A’);
(2) not all CpG mutations resulted in formation
of the p53 sites with S = 0.
(1) To compare different Alu subfamilies in terms of
their enrichment for various length spacers, in addi-
tion to the absolute numbers presented in Table 2,
we need to consider the ‘relative’ values (similar to
GC content). For example, consider the ratio (num-
ber of the p53 sites with S = 0) divided by (number
of all Alu elements in the subfamily). This ratio is
the highest for the Sg1 subfamily (58%) and exceeds
more than twofold the ratios for the other Alu sub-
families. In other words, the AluSg1 sequences are
characterized by the highest ‘content’ of p53 sites
with S = 0. But it does not mean that the members
of Sg1 subfamily experienced the highest CpG muta-
tion rate. As follows from Figure S4-H, the Sg1 sub-
family is unique in the sense that nearly all p53 sites
with spacer S = 0 are mapped to the Box B, while in
the other subfamilies the sites with S = 0 are
mapped to the Boxes A/A’ (Figures 4 and 5). The
consensus AluSg1 sequence (Figure 6, Box B) sug-
gests that most of the p53 sites in the Sg1 subfamily
originated without mutations in CpG (Figure 6), and
the AluSg1 elements have to be excluded from this
consideration.
(2) Furthermore, mutations CG:CG-to-CA:TG are
required not only for creation of the p53 sites with S
= 0, but also for the sites with S = 8 and S = 14 (see
consensus sequences in Figure 6, Box B). If we cal-
culate the cumulative ‘content’ of p53 sites with S =
0, 8 and 14 bp (Table 2), it will be the highest for
AluJo subfamily (35%). The next are the FLAM-C
and AluSp subfamilies with 30%. The youngest sub-
families in Table 2, AluSc and AluY, have very low
contents, 8% and 3%, respectively.
Thus, we see that the old AluJo subfamily has the
highest fraction of the p53 sites which likely origi-
nated through CpG mutations.
The authors touch on a very interesting issue towards
the end of the discussion, where they mention that p53
binding of Alus effectively silences their transcription by
disrupting assembly of the pol III machinery. However,
this discussion is curiously devoid of biological context
with respect to the effects of Alu transcription on cellu-
lar function. I would urge the authors to consider spec-
ulating further on the biological significance of this idea.
The dysregulation of TEs has previously been associated
with a number of disorders including cancer. However,
the classic models for the role of p53 in tumorgenesis
are related to transcriptional activation and/or repres-
sion of host genes, and indeed much of the focus of this
manuscript is on the potential effects of Alu carried p53
binding sites on host genes. But the work reported here
suggests the possibility that defects in the function of
p53 could lead to cancer via dysregulation (specifically
upregulation) of the Alu elements themselves.
Authors’ response: Thank you for the suggestion -
we included more biologically-related speculations in
the last section of Discussion.
The authors propose a selective model whereby young
Alus transpose near the promoter regions of host genes
bearing p53 binding sites that disrupt the expression of
the element, thereby mitigating some of its potential
deleterious effects, and also can effect the regulation of
the host gene. It is difficult to reconcile this model with
the observation that younger Alus are enriched for the
short spacer binding sites in the A-box region that
appear to have evolved via CpG methylation and deami-
nation. Thus, the intitial effect of many of these inser-
tions would not be to bring that p53 binding site and so
selection could not act at that point. This model is also
inconsistent with the observation that young Alu ele-
ments are depleted near genes relative to older Alu ele-
ments.
Authors’ response: In our opinion, not only the
young Alus bear p53 binding sites that could poten-
tially disrupt the expression of the Alu element
(through the interaction between p53 N-terminus
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Alu elements may also play a similar role. As shown
in Figure 6, all Alu subfamilies (from FLAM to
AluY) share a highly conserved p53 site in the Box
A. All Alus except AluSc and AluY bear a site in the
Box B with spacer S = 3, 8 or 14 bp. It is conceiva-
ble that p53 could bind these sites, disrupting the
expression of Alu elements and at the same time,
playing a regulatory role int h et r a n s c r i p t i o no f
nearby host genes.
With respect to the analyses reported here, there are a
few rather qualitative conclusions drawn from data that
could be quantitatively and statistically analyzed in such a
way as to provide more definitive results. The trends that
the authors point to do seem to be there, but a more quan-
titative analysis could provide additional support for their
conclusions. I provide a few suggestions to this end below.
First, the method for comparing the p53 binding site
spacer length distributions for repetitive and nonrepeti-
tive DNA seems indirect. It appears as if the authors
compared, 1) the entire genome including repeats and
non-repeats (see filled circles in Figure 3) with 2) only
the non-repeat part of the genome (open circles in
Figure 3). In other words, the non-repetitive fraction
analysis in part 2 was done on a subset of the entire
genome analysis in part 1. Why not directly compare
the spacer distributions for the repeat and non-repeat
parts of the genome directly?
Authors’ response: In Figure 3, we compared the
whole genome with the non-repeat part of the gen-
ome. The latter is characterized by nearly constant
frequency of occurrence of the spacer S (where S
varies from 0 to 20 bp). This means that the peaks
in the spacer length distribution originate (almost)
entirely due to repeats. The approximate values for
the repeat part of the genome can be easily obtained
by subtracting 60,000 from the values presented in
Figure 3 for the whole genome. (Approximate
because those few p53 BSs that occur at the borders
of the repeat elements would be eliminated from
consideration.) In addition, the spacer length distri-
bution for Alu repeats is given in Figure 4A.
Second, the relationship between the age of Alu ele-
ments and the length of the spacer, which has important
functional implications since short spacers tend to bind
p53 with higher affinity, is quite interesting. The trend
the authors highlight in Table 2 does seem somewhat
apparent, but this could benefit from a more definitive
quantitative analysis. In particular, some of the data fit
the trend of decreasing spacer length with element age,
but others, such as the youngest family AluY, do not.
The relative age of the families could be correlated with
the average spacer length for each class, or perhaps sim-
ply the length of the most prevalent spacer, to more
quantitatively evaluate the trend.
Authors’ response: Unfortunately, the estimates of
the average age of Alu elements are contradictory in
two aspects. First, there is uncertainty regarding the
order of the Alu subfamilies. For example, Kapitonov
& Jurka [72] proposed that the subfamily Sx is
younger than Sq, whereas several other studies,
including one from the Pevzner group [73], sug-
gested that Sx is older than Sq. Second, the ages of
A l us u b f a m i l i e se s t i m a t e db yv a r i o u sg r o u p sd i f f e r
substantially. For instance, Kapitonov & Jurka esti-
mated the age of AluJo to be ~80 Myr, while the
corresponding estimate made by Pevzner and collea-
gues is ~60 Myr.
Given the noticeable discrepancy and uncertainty of
the age estimate of Alu subfamilies in the literature,
we preferred to present the dependence as shown in
Table 2 - at the qualitative level, all is clear here. A
quantitative evaluation of the correlation between
the average spacer length and the age of the Alu
subfamilies is hardly possible, at least for a while.
Minor points: There are a few statements that are not
directly supported by the data or the literature cited.
On page 4, Haussler and co-workers [14] are cited as
substantiating previous results that TEs (LTRs) contain
p53 binding sites. The references cited as providing the
original observations that are substantiated by Wang et
al. [14] are both abstracts from conference proceedings;
thus it is not clear what they report. Is it not the case
that the Haussler paper was the first to show that TE
sequences bind p53 genome-wide based on experimental
evidence as opposed to simply binding site predictions?
It would help to clarify this.
Authors’ response: Yes, it is correct that Wang et al.
[14] were the first to show that numerous p53 bind-
ing sites detected in the p53-ChIP experiments [7]
are embedded in TE sequences. We made appropri-
ate changes in the Background, to make this clear.
On the other hand, in the two short abstracts pub-
lished earlier [12,13] we showed that “simply” pre-
dicted p53 binding sites reside in TEs genome-wide.
Unfortunately, we were unable to publish a detailed
description of our results in 2003, because at that
time the idea of thousands (let alone millions) of
p53 sites residing in ‘junk DNA’ was absolutely
unacceptable in the p53 community.
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‘remarkable’ that most of the predicted Alu-derived p53
binding sites are clustered in the same regions of the
elements as seen for the well characterized response ele-
ments. I don’t understand why this is remarkable in
light of the fact that one would expect p53 to bind Alu
elements in the regions that contain consensus binding
site motifs.
Authors’ response: In our opinion, this is “remark-
able” because numerous predicted p53 BSs behave
similar to those few experimentally validated p53
REs that bind to Alu repeats. This point is discussed
in detail in Conclusions (third paragraph). However,
to comply with the Reviewer’s objection, we substi-
tuted “remarkably” by “importantly.”
On page 6, the authors state that “promoter regions are
enriched with Alu elements” to underscore the potential
of Alu-derived p53 binding sites to influence host gene
regulation and cite Polak and Domany [40] in support of
this statement. In fact, this manuscript and several others
show that Alus, along with other TEs, are actually substan-
tially depleted in proximal promoter regions adjacent to
transcriptional start sites (TSS) and then steadily increase
in frequency moving away from the TSS. Several kb distal
from the TSS Alus are indeed found in slightly higher fre-
quencies than for the genome as a whole, and intergenic
regions in particular, but this can be attributed simply to
the fact that Alus are enriched in-and-around genes.
Authors’ response: Thank you for the correction -
indeed, these are the upstream regions of the TSS (sev-
eral kilobases in length) that are enriched with Alu ele-
ments, not the promoters themselves, as we wrote. We
changed the end of the Background accordingly.
Additional material
Additional file 1: Supplementary Tables S1-S3.
Additional file 2: Supplementary Figure S1: Alignment of p53
functional REs with the consensus sequences of human repeats.
Additional file 3: Supplementary Figure S2: Alignment of the p53
functional REs and their flanks with the consensus sequences of
Alu repeats.
Additional file 4: Supplementary Figure S4: Occurrence of putative
p53 sites in the subfamilies FLAM-A (A), FLAM-C (B), AluJb (C),
AluSq (D), AluSg (E), AluSp (F), AluSc (G), AluSg1 (H) and AluY (I).
Additional file 5: Supplementary Figure S3: PWM-20 score
distributions for p53 REs and in vivo binding sites.
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